Kevin

Founder & Principal Consultant

Summary

Kevin is a seasoned pharmaceutical executive and consultant with extensive expertise in CMC, technical innovation, and business development. Over his career, he has led critical programs, including advancing Hepatitis-C treatments to market and implementing continuous manufacturing technologies. As a trusted advisor, Kevin excels in navigating regulatory landscapes, enhancing operational efficiencies, and accelerating the development timeline from lab to market.

Core Expertise

  • CMC/Formulation Leadership for Development and Launch
  • Regulatory Approvals and Quality by Design (QbD) Strategy Implementation
  • Process Design, Spray Drying, and Continuous Manufacturing
  • Market Analysis for CDMOs and Technology Companies
  • Scaling and Optimizing Technical Operations

Career Highlights

Scientist, Vertex: Led the Hepatitis-C program to commercialization and introduced industry-transforming continuous manufacturing methods.
VP BD & CMC and Co-Founder, Trek Therapeutics: Secured six in-licensed assets with minimal upfront costs and initiated clinical trials within the company’s first year.
VP Technical Operations and QA, Living Proof: Streamlined manufacturing processes, achieving an efficiency leap from 2 sigma to 5 sigma.

Contact Us Today